Chemical Compound

Paliperidone

CAS Registry Number 144598-75-4

Back to search Request a Quote

Primary Record

Paliperidone

In stock: 2,838 g
Purity: 98.3 %
CAS: 144598-75-4

Compound Identifiers & Properties

CAS: 144598-75-4
PubChem CID: 115237
SMILES: CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
Canonical SMILES: Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O

Names & Synonyms

Paliperidone
9-Hydroxyrisperidone
Invega
144598-75-4
9-OH-risperidone
xeplion
Paliperidona
Invega Sustenna
Paliperidone-d4
paliperidonum
Trevicta
9-Hydroxy-risperidone
Paliperidone [INN]
PALLIPERIDONE
9 OH risperidone
Paliperidone/Invega
9 Hydroxyrisperidone
Invega (TN)
9-Hydroxy risperidone
9-hydroxy risperidone
Paliperidone Palmitate
9 Hydroxy risperidone
C23H27FN4O3
Paliperidone (Standard)
Dehydrocorydaline nitrate
RefChem:56592
Risperidone-M 9-hydroxy
(R)-9-Hydroxy Risperidone
CHEMBL1621
PALIPERIDONE [MI]
PALIPERIDONE [JAN]
Risperidone EP Impurity C
RO76477
D0B3UJ
PALIPERIDONE [USAN]
AC1L3GS8
(S)-9-Hydroxy Risperidone
PALIPERIDONE [VANDF]
MFCD00871802
DTXSID7049059
PALIPERIDONE [MART.]
HSDB 8148
JNS-007ER
MLS004773953
PALIPERIDONE [USP-RS]
PALIPERIDONE [WHO-DD]
RAC 9-HYDROXY RISPERIDONE
RO-76477
SCHEMBL436689
Paliperidone (JAN/USP/INN)
PMXMIIMHBWHSKN-UHFFFAOYSA-N
GTPL7258
orb1310964
Paliperidone9-hydroxyrisperidone
UNII-838F01T721
PALIPERIDONE [EMA EPAR]
R-76477
NSC-759623
SCHEMBL29409219
CHEBI:82978
CHEBI:83804
CTK8B3649
HY-A0019R
Paliperidone - Bio-X trade mark
Paliperidone [USAN:INN:BAN:JAN]
144598-75-4 (free base)
9-Hydroxyrisperidone-D4 solution
AOB1667
DTXCID30210372
JNS-010
N05AX13
Paliperidone, >=98% (HPLC)
MFCD09955571
BCPP000132
HMS3261B06
HMS3743M09
HMS3887K15
HMS5087B15
PALIPERIDONE [ORANGE BOOK]
AMY24885
BCP02338
HY-A0019
KS-00000W1B
MSK10469
**See P141000**
PALIPERIDONE [USP MONOGRAPH]
Tox21_500562
ABP000395
AN-759
ANW-42875
BDBM50252513
C23-H27-F-N4-O3
CID115237
EBC-13192
HB1798
Ro-92670
s1724
838F01T721
AKOS005266713
AKOS016339656
AKOS025392164
R 76477
AC-1282
ACN-050765
BCP9001047
CCG-221866
CM14424
CS-0386
CS-O-02070
DB01267
FP26725
KS-1279
LP00562
NSC 759623
PB27526
RL01805
RTC-030009
SDCCGSBI-0633730.P001
YF10040
Risperidone EP Impurity C; Paliperidone
NCGC00186014-01
NCGC00186014-12
NCGC00261247-01
9-Hydroxyrisperidone, 1mg/ml in Methanol
AK-77508
AS-13860
BC228519
BC677689
BP164223
Risperidone EP Impurity C (Paliperidone)
RO 76477
S451
SC-08807
SMR001456280
SY026871
3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
AB0018636
AB1010913
J508.304D
LS-134195
Paliperidone (depot injection, NanoCrystal)
Risperidone impurity, 9-hydroxyrisperidone-
TC-030009
9-Hydroxyrisperidone 1.0 mg/ml in Methanol
P1897
Paliperidone (injectable, NanoCrystal), Elan
RISPERIDONE IMPURITY C [EP IMPURITY]
ST24030055
4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-
C21516
D05339
EN300-119503
J10457
Q-4343
R76477
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
598P754
A937348
L023985
Q423292
SR-02000000862
4H-Pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-
I14-1945
SR-02000000862-3
BRD-A99888680-001-03-8
BRD-A99888680-001-04-6
(9RS)-3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl))ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido(1,2-a)pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-4H,6H,7H,8H,9H-pyrido[1,2-a]pyrimidin-4-one
Z1521553597
B0084-051542
130049-85-3
4H-Pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8-tetrahydro-9-hydroxy-2-methyl-
4H-Pyrido(2,1-a)pyrimidin-4-one, 6,7,8,9-tetrahydro-3-(2-(4-(6-fluro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-9-hydroxy-2-methyl-
Paliperidone (depot injection, NanoCrystal), Johnson & Johnson
Paliperidone, United States Pharmacopeia (USP) Reference Standard
RISPERIDONE IMPURITY, 9-HYDROXYRISPERIDONE- [USP IMPURITY]
1020719-55-4
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
Paliperidone, 99%, a potent D2 and 5-HT2A antagonist - 10MG 10mg
(+/-)-3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
(9R)-3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
(9RS)-3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
(9RS)-3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
(9RS)-3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (9-Hydroxyrisperidone)
(9RS)-3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one; Risperidone Imp. C (EP); 9-Hydroxyrisperidone; Paliperidone; R 76477; RO 76477; Risperidone Impurity C
13005-09-9
147663-01-2
147663-04-5
199739-10-1
3-(2-(4-(6-FLUORO-1,2-BENZISOXAZOL-3-YL)-1-PIPERIDINYL)ETHYL)-6,7,8,9-TETRAHYDRO-9-HYDROXY-2-METHYL-4H-PYRIDO(1,2-A)PYRIMIDIN-4-ONE
3-(2-(4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-4H,6H,7H,8H,9H-pyrido(1,2-a)pyrimidin-4-one
3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-(2-[4-(6-FLUORO-1,2-BENZOXAZOL-3-YL)PIPERIDIN-1-YL]ETHYL)-9-HYDROXY-2-METHYL-4H,6H,7H,8H,9H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE
3-[ 2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[ 2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-9-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, 9-Hydroxyrisperidone
3-[2-[4-(6-Fluoro-1,2-Benzisoxazol-3-yl)-1-Piperidinyl]Ethyl]-9-Hydroxy-6,7,8,9-Tetrahydro-2-Methyl-4H-Pyrido[1,2-a]-Pyrimidin-4-One
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidyl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-FLUOROBENZO[D]ISOXAZOL-3-YL)-1-PIPERIDYL]ETHYL]-7-HYDROXY-4-METHYL-1,5-DIAZABI-CYCLO[4.4.0]DECA-3,5-DIEN-2-ONE
3-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)-1-piperidinyl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-alpha]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-9-hydroxy-2-methyl-6,7,8,9- tetrahydro-pyrido[1,2-a]pyrimidin-4-one
4H-yrido[1,2-]yrimidin-4-ne, 3-2-4-(6-luoro-1,2-enzisoxazol-3-l)-1-iperidinyl]thyl]-6,7,8,9-etrahydro-9-ydroxy-2-ethyl-
6,7,8,9-Tetrahydro-3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-9-hydroxy-2-methyl-4H-pyrido[2,1-a]pyrimidin-4-one
6,7,8,9-Tetrahydro-3-(2-(4-(6-fluro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-9-hydroxy-2-methyl-4H-pyrido[2,1-a]pyrimidin-4-one
9-Hydroxyrisperidone solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material